Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

International Journal of Urology

Volumn 13, Issue 2, 2006, Pages 142-147

  Kim, Hyung Jee ^a,b   Sohng, Inho ^a   Hwang, Cheol Ho ^b   Park, Ji Young ^b  

^a Departments of Rehabilitation Medicine   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Cytokeratin 20; Proteomics; Seminal vesicle secretory protein VI

Indexed keywords

ALPHA ACTIN; CYTOKERATIN 20; HEAT SHOCK PROTEIN 27; LIPOPROTEIN; MYOCARDIN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; SEMINAL VESICLE SECRETORY PROTEIN; SEMINAL VESICLE SECRETORY PROTEIN 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER MUCOSA; CONTROLLED STUDY; EXCISION; HYPERPLASIA; IMAGE ANALYSIS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; SEMINAL VESICLE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BIOLOGICAL MARKERS; BUTYLHYDROXYBUTYLNITROSAMINE; KERATIN-20; KERATINS; MALE; PRECANCEROUS CONDITIONS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SEMINAL VESICLE SECRETORY PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 33644843348     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01248.x     Document Type: Article

References (25)

1. Lee C Lee ES Choi H et al. Incidence estimation of genitourinary cancer in Korea JKorean MedSci 1992 7 154 61
2. Richie JP Shipley WU Yogoda A Cancer of the bladder In Devita VT Hellman S Rosenberg SA (eds) Cancer: Principles and Practice of Oncology JB Lippincott Philadelphia 1989 1008 22
3. Bonner R Hemstreet GP Fradent Y Rao JY Min KW Hurst RE Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells Cancer 1993 72 2461 9
4. Klein A Zemer R Buchumensky V Klaper R Nissenkorn I Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma Cancer 1998 82 349 54
5. Landry J Chretien P Laszlo A Lambert H Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cells JCell Physiol 1991 147 93 101
6. Hahn GM van Kersen I Isolation and initial characterization of thermoresistant RIF tumor cell strains Cancer Res 1988 48 1803 7
7. Nooter K Stoter G Molecular mechanisms of multidrug resistance in cancer chemotherapy PatholResPract 1996 192 768 80
8. Falk MH Issels RD Hyperthermia in oncology IntJHyperthermia 2001 17 1 18
9. Rau B Gaestel M Wust P et al. Preoperative treatment of rectal cancer with radiation, chemotherapy and hyperthermia: analysis of treatment efficacy and heat-shock response RadiatRes 1999 151 479 88
10. Laszlo A Venetianer A Heat resistance in mammalian cells: lessons and challenges AnnN Y AcadSci 1998 851 169 78
11. Rao KVN Detrisac CJ Steele VE Hawk E Kelloff GJ McCormick DL Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder Carcinogenesis 1996 17 1435 8
12. Malmstrom PU Busch C Norlen BJ Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up ScandJUrolNephrol 1987 21 185 95
13. Fukushima S Murasaki G Hirose M Nakanishi K Hasegawa R Ito N Histopathological analysis of preneoplastic changes during N-butyl-N-(4- hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats Acta PatholJpn 1982 32 243 50
14. Morse MA Stoner GD Cancer chemoprevention: principles and prospects Carcinogenesis 1993 14 1737 46
15. Srinivas PR Kramer BS Srivastava S Trends in biomarker research for cancer detection Lancet 2001 2 698 704
16. Larsson T Bergstrom J Nilsson C Karlsson KA Use of an affinity proteomics approach for the identification of low-abundant bacterial adhesins as applied on the Lewis (b) -binding adhesin of Helicobacter pylori FEBS Lett 2000 469 155 8
17. Charlwood J Skehel JM Camilleri P Analysis of N-linked oligosaccharides released from glycoproteins separated by two-dimensional gel electrophoresis AnalBiochem 2000 284 49 59
18. Wilkins MR Sanchez JC Gooley AA et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it BiotechnolGenEngRev 1995 13 19 50
19. Pandey A Mann M Proteomics to study genes and genomes Nature 2000 405 837 46
20. Simpson RJ Dorow DS Cancer proteoics: from signaling networks to tumor markers Trends Biotechnol 2001 19 Suppl. 10 40 8
21. Rotem D Cassel A Lindenfeld N et al. Urinary cytokeratin 20 as a marker for transitional cell carcinoma EurUrol 2000 37 601 4
22. Moll R Lowe A Laufer J Franke WW Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies AmJPathol 1992 140 427 47
23. Southgate J Hutton KA Thomas DF Trejdosiewicz LK Normal human urothelial cells in vitro: proliferation and induction of stratification LabInvest 1994 71 583 94
24. Morel L Brochard D Manin M Simon AM Jean C Veyssiere G Mouse seminal vesicle secretory protein of 99 amino acids (MSVSP99): characterization and hormonal and developmental regulation JAndrol 2001 22 549 57
25. Tufano MA Porta R Farzati B et al. Rat seminal vesicle protein SV-IV and its transglutaminase-synthesized polyaminated derivative SPD2-SV-IV induce cytokine release from human resting lymphocytes and monocytes in vitro CellImmunol 1996 168 148 57